The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List


Mon, Dec 9, 5:30 PM, Zacks
HWAY and SulAmerica Join Forces, Shares Fall - Analyst Blog
Healthways and SulAmerica enter into five year agreement but stocks continue to be down for HWAY.

Mon, Dec 9, 2:00 PM, Zacks
Omnicare Raises Dividend, Approves Share Repurchase - Analyst Blog
OCR believes in a consistent dividend payment policy with raises every year

BG Medicine Inc (BGMD)

BG Medicine is a diagnostics company focused on the development and commercialization of cardiovascular diagnostic tests. Co. is commercializing two diagnostic tests, the first of which is the BGM Galectin-3® test, a novel assay for measuring galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of patients diagnosed with heart failure. Co.'s second diagnostic test is the CardioSCORE™ test, which is designed to identify individuals at high risk for near-term cardiovascular events, such as heart attack and stroke. Co. is also developing CardioSCORE as an aid in the assessment of near-term risk for cardiovascular death due to acute atherothrombosis.

Company Name:  BG Medicine Inc
Sector:  Biotechnology
Number of ETFs Holding BGMD:  1
Total Market Value Held by ETFs:  $79748
Total Market Capitalization:  $36.00M
% of Market Cap. Held by ETFs:  0.22%
April 20, 2014    4:14 AM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Trade BGMD Now:

Strong Buy (4.00 out of 4)
88th percentile
(ranked higher than approx. 88% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

BG Medicine Inc (BGMD) Page | The Online Investor | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.